(CIDRAP News) – Three large, multi-center studies now in the enrollment stage will assess whether such approaches as a combination of antiviral drugs or the use of borrowed antibodies can improve on existing treatments for influenza, the National Institutes of Health (NIH) announced today.
(CIDRAP News) – The number of swine-origin H3N2 (variant H3N2, or H3N2v) influenza cases in the United States has climbed by 9 in the past week, to 305, and another rare swine-origin variant, H1N1v, has cropped up in Missouri, the Centers for Disease Control and Prevention (CDC) reported today.
(CIDRAP News) The US Centers for Disease Control and Prevention (CDC) today reported two more infections with swine-origin H3N2 influenza, including a case first announced by Maine 3 days ago and an additional illness in an Indiana patient.
The CDC also said flu activity in the United States is still at low levels, a pattern the World Health Organization (WHO) is also seeing in most parts of the world.
(CIDRAP News) A few of the world's tropical countries are reporting active flu transmission, as the flu season continues in Australia and New Zealand, though activity is declining, the World Health Organization (WHO) reported today.
(CIDRAP News) Though influenza activity is low in most nations, some are seeing active transmission, including Cuba, Bolivia, Cameroon, and parts of Southeast Asia, the World Health Organization said today in an update.
Cuba and El Salvador have reported increasing circulation of influenza A (H3N2), a strain that peaked in Honduras in the middle of August.
(CIDRAP News) Australian public health officials yesterday reported a cluster of oseltamivir (Tamiflu)-resistant 2009 H1N1 infections, one of the largest to date, centered in one region of New South Wales state.
(CIDRAP News) When the World Health Assembly (WHA) considers the fate of the remaining stocks of smallpox virus this week, the debate is likely to be framed in part by a report from a group of independent experts that says the only strong reason for keeping the virus is to satisfy strict regulatory requirements for new vaccines and antivirals.